Voglio sapere a riguardo di…

Federal Register / Vol. 86, No. 213 / Monday, November 8, 2021 / Notices The meeting will be held on October 2021, 2021, from 10:00 a.m. to 5:00 p.m., EDT times subject to change. The docket is currently open to receive written comments. Written comments must be received on or before October 21, 2021.
SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the meeting of the Advisory Committee on Immunization Practices ACIP; October 20, 2021, 10:00 a.m.5:00 p.m., EDT, and October 21, 2021, 10:00 a.m.5:00
p.m., EDT times subject to change, in the original FRN.
The virtual meeting was published in the Federal Register on Wednesday, September 22, 2021, Volume 86, Number 181, pages 5268352684.
The virtual meeting is being amended to change the date the docket was opened to receive written public comments, and updates to the Matters To Be Considered and Written Public Comment sections of the notice and should read as follows:
DATES: The meeting will be held on October 2021, 2021, from 10:00 a.m. to 5:00 p.m., EDT times subject to change. The public may submit written comments from October 7, 2021 through October 21, 2021.
Matters To Be Considered: The agenda will include discussions on herpes zoster vaccines, influenza vaccines, pneumococcal vaccine, and COVID19
vaccines. Recommendation votes on herpes zoster vaccine, pneumococcal vaccine, and COVID19 vaccines are scheduled. No Vaccines for Children VFC votes are scheduled. Agenda items are subject to change as priorities dictate. For more information on ACIP
please visit the ACIP website: http
www.cdc.gov/vaccines/acip/index.html.
Written Public Comment: The docket will be opened to receive written comments on October 7, 2021. Written comments must be received on or before October 21, 2021.
The virtual meeting is open to the public.
FOR FURTHER INFORMATION CONTACT:
Stephanie Thomas, ACIP Committee Management Specialist, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Road NE, MSH248, Atlanta, GA 30329
4027; Telephone: 4046398367; Email:
ACIP@cdc.gov.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other
lotter on DSK11XQN23PROD with NOTICES1

DATES:

VerDate Sep<11>2014

18:37 Nov 05, 2021

Jkt 256001

committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.

61767

Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
FR Doc. 202124322 Filed 11521; 8:45 am BILLING CODE 416318P

FR Doc. 202124320 Filed 11521; 8:45 am BILLING CODE 416318P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel SEPRFACK22003, Emerging Infections Sentinel Networks EISN Research.
Date: January 11, 2022.
Time: 10:00 a.m.5:00 p.m., EST.
Place: Teleconference, Centers for Disease Control and Prevention, Room 1080, 8
Corporate Square Boulevard, Atlanta, Georgia 303294027.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US81, Atlanta, Georgia 303294027, Telephone:
404 7188833, Email: GAnderson@cdc.gov.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and
PO 00000

Frm 00021

Fmt 4703

Sfmt 4703

Centers for Medicare & Medicaid Services Document Identifiers: CMS10280

Agency Information Collection Activities: Submission for OMB
Review; Comment Request Centers for Medicare &
Medicaid Services, Health and Human Services HHS.
ACTION: Notice.
AGENCY:

The Centers for Medicare &
Medicaid Services CMS is announcing an opportunity for the public to comment on CMS intention to collect information from the public. Under the Paperwork Reduction Act of 1995
PRA, federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agencys functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.

SUMMARY:

Comments on the collections of information must be received by the OMB desk officer by December 8, 2021.
ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/
PRAMain. Find this particular information collection by selecting Currently under 30-day ReviewOpen for Public Comments or by using the search function.
DATES:

E:FRFM08NON1.SGM

08NON1